Trial
NCT03151408
An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid Leukemia
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Helsinn Healthcare SA
Collaborators
Clinipace Worldwide
Condition
Acute Myeloid Leukemia
Intervention
Pracinostat
Why stopped
The IDMC recommended to stop the study prematurely due to a lack of efficacy.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-10